Kalprotektin (feces)
Senast reviderad:
Sakkunnig:Anders Kallner
- Waugh, N, Cummins, E, Royle, P, et al. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess 2013: 17; xv-xix, 1–211. PMID: 24286461. PubMed
- Turvill J. High negative predictive value of a normal faecal calprotectin in patients with symptomatic intestinal disease. Frontline Gastroenterology 2012; 3: 21- 8. PubMed
- SBU Kommenterar 2014-09-04: Bestämning av kalprotektin i feces kan skilja mellan inflammatorisk tarmsjukdom och icke-inflammatoriska tarmbesvär. www.sbu.se
- Sipponon T, Savilathi E, Kolho KL, et al. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 2007; 13: 1-7. PubMed
- Roseth A, Fagerhol MK, Wasiluk J, et al. A new calprotectin PoC device correlates with ELISA and separates between endoscopic assessed mucosal healing and active ulcerative colitis. Gastroenterology 2007; 132: A175. Gastroenterology
- Montalto M, Santoro L; Curgliano V, et al. Faecal calprotectin concentrations in untreated celiac patients. Scand J Gastroenterol 2007; 42: 957-61. PubMed
- vonRoon AC, Karamountzos L, Purkayastha S, et al. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol 2007; 102: 803-13. PubMed
- Røseth AG, Aadland E, Grzyb K. Normalization of fecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol 2004; 39: 1017-20. PubMed
- Nilsson-Ehle P, Berggren Söderlund M, Theodorsson E et al (red. Laurells Klinisk kemi i praktisk medicin. Lund: Studentlitteratur, 2012.
- Anders Kallner, docent och f d överläkare, Karolinska universitetslaboratoriet, Karolinska universitetssjukhuset